 | • レポートコード：D005-00819 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ポイントオブケア感染症診断/検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。ポイントオブケア感染症診断/検査の種類別市場規模（HIV POC、クロストリジウムディフィシルPOC、HBV POC、肺炎または連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、その他の感染症POC）、用途別市場規模（病院、クリニック、家庭、介護福祉施設、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Cardinal Health、Siemens Healthineers、Thermo Fisher Scientific Inc、Trinity Biotech、F. Hoffmann-La Roche Ltd、Bio-Rad Labs Inc.、Chembio Diagnostics Inc.、BD & Company、Quest Diagnostics Inc.、OJ-Bio Ltd.、bioMérieux SA、Ortho-Clinical Diagnostics、Trivitron Healthcare、Sight Diagnostics Ltd.、Gene POC ・地域別グローバル市場分析 2015年-2020年 ・ポイントオブケア感染症診断/検査の北米市場（アメリカ、カナダ、メキシコ） ・ポイントオブケア感染症診断/検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ポイントオブケア感染症診断/検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ポイントオブケア感染症診断/検査の南米市場（ブラジル、アルゼンチン） ・ポイントオブケア感染症診断/検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：HIV POC、クロストリジウムディフィシルPOC、HBV POC、肺炎または連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、その他の感染症POC ・用途別分析：病院、クリニック、家庭、介護福祉施設、研究所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Point-of-Care Infectious Disease Diagnostics/Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 1257.8 million by 2025, from USD 1026.6 million in 2019.
The Point-of-Care Infectious Disease Diagnostics/Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Point-of-Care Infectious Disease Diagnostics/Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Point-of-Care Infectious Disease Diagnostics/Testing market has been segmented into:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
By Application, Point-of-Care Infectious Disease Diagnostics/Testing has been segmented into:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Point-of-Care Infectious Disease Diagnostics/Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Point-of-Care Infectious Disease Diagnostics/Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Point-of-Care Infectious Disease Diagnostics/Testing market.
The report offers in-depth assessment of the growth and other aspects of the Point-of-Care Infectious Disease Diagnostics/Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Point-of-Care Infectious Disease Diagnostics/Testing Market Share Analysis
Point-of-Care Infectious Disease Diagnostics/Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Point-of-Care Infectious Disease Diagnostics/Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Point-of-Care Infectious Disease Diagnostics/Testing sales, revenue and market share for each player covered in this report.
The major players covered in Point-of-Care Infectious Disease Diagnostics/Testing are:
Abbott
Cardinal Health
Siemens Healthineers
Thermo Fisher Scientific Inc
Trinity Biotech
F. Hoffmann-La Roche Ltd
Bio-Rad Labs Inc.
Chembio Diagnostics Inc.
BD & Company
Quest Diagnostics Inc.
OJ-Bio Ltd.
bioMérieux SA
Ortho-Clinical Diagnostics
Trivitron Healthcare
Sight Diagnostics Ltd.
Gene POC
Table of Contents
1 Point-of-Care Infectious Disease Diagnostics/Testing Market Overview
1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics/Testing
1.2 Classification of Point-of-Care Infectious Disease Diagnostics/Testing by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type in 2019
1.2.3 HIV POC
1.2.4 Clostridium difficile POC
1.2.5 HBV POC
1.2.6 Pneumonia or Streptococcus associated infections
1.2.7 Respiratory syncytial virus (RSV) POC
1.2.8 HPV POC
1.2.9 Influenza/Flu POC
1.2.10 Other Infectious Disease POC
1.3 Global Point-of-Care Infectious Disease Diagnostics/Testing Market by Application
1.3.1 Overview: Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Global Point-of-Care Infectious Disease Diagnostics/Testing Market by Regions
1.4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Point-of-Care Infectious Disease Diagnostics/Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Point-of-Care Infectious Disease Diagnostics/Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cardinal Health
2.2.1 Cardinal Health Details
2.2.2 Cardinal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cardinal Health SWOT Analysis
2.2.4 Cardinal Health Product and Services
2.2.5 Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Siemens Healthineers SWOT Analysis
2.3.4 Siemens Healthineers Product and Services
2.3.5 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific Inc
2.4.1 Thermo Fisher Scientific Inc Details
2.4.2 Thermo Fisher Scientific Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific Inc SWOT Analysis
2.4.4 Thermo Fisher Scientific Inc Product and Services
2.4.5 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Trinity Biotech
2.5.1 Trinity Biotech Details
2.5.2 Trinity Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Trinity Biotech SWOT Analysis
2.5.4 Trinity Biotech Product and Services
2.5.5 Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche Ltd
2.6.1 F. Hoffmann-La Roche Ltd Details
2.6.2 F. Hoffmann-La Roche Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche Ltd SWOT Analysis
2.6.4 F. Hoffmann-La Roche Ltd Product and Services
2.6.5 F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bio-Rad Labs Inc.
2.7.1 Bio-Rad Labs Inc. Details
2.7.2 Bio-Rad Labs Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bio-Rad Labs Inc. SWOT Analysis
2.7.4 Bio-Rad Labs Inc. Product and Services
2.7.5 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Chembio Diagnostics Inc.
2.8.1 Chembio Diagnostics Inc. Details
2.8.2 Chembio Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Chembio Diagnostics Inc. SWOT Analysis
2.8.4 Chembio Diagnostics Inc. Product and Services
2.8.5 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 BD & Company
2.9.1 BD & Company Details
2.9.2 BD & Company Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BD & Company SWOT Analysis
2.9.4 BD & Company Product and Services
2.9.5 BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Quest Diagnostics Inc.
2.10.1 Quest Diagnostics Inc. Details
2.10.2 Quest Diagnostics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Quest Diagnostics Inc. SWOT Analysis
2.10.4 Quest Diagnostics Inc. Product and Services
2.10.5 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 OJ-Bio Ltd.
2.11.1 OJ-Bio Ltd. Details
2.11.2 OJ-Bio Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 OJ-Bio Ltd. SWOT Analysis
2.11.4 OJ-Bio Ltd. Product and Services
2.11.5 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 bioMérieux SA
2.12.1 bioMérieux SA Details
2.12.2 bioMérieux SA Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 bioMérieux SA SWOT Analysis
2.12.4 bioMérieux SA Product and Services
2.12.5 bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ortho-Clinical Diagnostics
2.13.1 Ortho-Clinical Diagnostics Details
2.13.2 Ortho-Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ortho-Clinical Diagnostics SWOT Analysis
2.13.4 Ortho-Clinical Diagnostics Product and Services
2.13.5 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.14 Trivitron Healthcare
2.14.1 Trivitron Healthcare Details
2.14.2 Trivitron Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Trivitron Healthcare SWOT Analysis
2.14.4 Trivitron Healthcare Product and Services
2.14.5 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.15 Sight Diagnostics Ltd.
2.15.1 Sight Diagnostics Ltd. Details
2.15.2 Sight Diagnostics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Sight Diagnostics Ltd. SWOT Analysis
2.15.4 Sight Diagnostics Ltd. Product and Services
2.15.5 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
2.16 Gene POC
2.16.1 Gene POC Details
2.16.2 Gene POC Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Gene POC SWOT Analysis
2.16.4 Gene POC Product and Services
2.16.5 Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share
3.2.2 Top 10 Point-of-Care Infectious Disease Diagnostics/Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Regions
4.2 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
4.5 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
5 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries
5.1 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
5.2 USA Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
6 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries
6.1 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
6.2 Germany Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
6.3 UK Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
6.4 France Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries
7.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
7.2 China Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
7.5 India Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
8 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries
8.1 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
8.2 Brazil Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Point-of-Care Infectious Disease Diagnostics/Testing by Countries
9.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Type (2019-2024)
10.3 HIV POC Revenue Growth Rate (2015-2025)
10.4 Clostridium difficile POC Revenue Growth Rate (2015-2025)
10.5 HBV POC Revenue Growth Rate (2015-2025)
10.6 Pneumonia or Streptococcus associated infections Revenue Growth Rate (2015-2025)
10.7 Respiratory syncytial virus (RSV) POC Revenue Growth Rate (2015-2025)
10.8 HPV POC Revenue Growth Rate (2015-2025)
10.9 Influenza/Flu POC Revenue Growth Rate (2015-2025)
10.10 Other Infectious Disease POC Revenue Growth Rate (2015-2025)
11 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Segment by Application
11.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Application (2015-2020)
11.2 Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Home Revenue Growth (2015-2020)
11.6 Assisted Living Healthcare Facilities Revenue Growth (2015-2020)
11.7 Laboratories Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast (2021-2025)
12.1 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Size Forecast (2021-2025)
12.2 Global Point-of-Care Infectious Disease Diagnostics/Testing Market Forecast by Regions (2021-2025)
12.3 North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
12.4 Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
12.6 South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Point-of-Care Infectious Disease Diagnostics/Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 7. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 10. Abbott Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Cardinal Health Corporate Information, Location and Competitors
Table 12. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 13. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2018-2019)
Table 14. Cardinal Health SWOT Analysis
Table 15. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 16. Cardinal Health Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Siemens Healthineers Corporate Information, Location and Competitors
Table 18. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 19. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 20. Siemens Healthineers SWOT Analysis
Table 21. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 22. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Inc Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 25. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific Inc SWOT Analysis
Table 27. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 28. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Trinity Biotech Corporate Information, Location and Competitors
Table 30. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 31. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 32. Trinity Biotech SWOT Analysis
Table 33. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 34. Trinity Biotech Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. F. Hoffmann-La Roche Ltd Corporate Information, Location and Competitors
Table 36. F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 37. F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 38. F. Hoffmann-La Roche Ltd SWOT Analysis
Table 39. F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 40. F. Hoffmann-La Roche Ltd Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bio-Rad Labs Inc. Corporate Information, Location and Competitors
Table 42. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 43. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 44. Bio-Rad Labs Inc. SWOT Analysis
Table 45. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 46. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Chembio Diagnostics Inc. Corporate Information, Location and Competitors
Table 48. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 49. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 50. Chembio Diagnostics Inc. SWOT Analysis
Table 51. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 52. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BD & Company Corporate Information, Location and Competitors
Table 54. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 55. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 56. BD & Company SWOT Analysis
Table 57. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 58. BD & Company Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Quest Diagnostics Inc. Corporate Information, Location and Competitors
Table 60. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 61. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 62. Quest Diagnostics Inc. SWOT Analysis
Table 63. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 64. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. OJ-Bio Ltd. Corporate Information, Location and Competitors
Table 66. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 67. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 68. OJ-Bio Ltd. SWOT Analysis
Table 69. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 70. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. bioMérieux SA Corporate Information, Location and Competitors
Table 72. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 73. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 74. bioMérieux SA SWOT Analysis
Table 75. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 76. bioMérieux SA Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Ortho-Clinical Diagnostics Corporate Information, Location and Competitors
Table 78. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 79. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 80. Ortho-Clinical Diagnostics SWOT Analysis
Table 81. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 82. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Trivitron Healthcare Corporate Information, Location and Competitors
Table 84. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 85. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 86. Trivitron Healthcare SWOT Analysis
Table 87. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 88. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Sight Diagnostics Ltd. Corporate Information, Location and Competitors
Table 90. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 91. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 92. Sight Diagnostics Ltd. SWOT Analysis
Table 93. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 94. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Gene POC Corporate Information, Location and Competitors
Table 96. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Major Business
Table 97. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Total Revenue (USD Million) (2017-2018)
Table 98. Gene POC SWOT Analysis
Table 99. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Product and Solutions
Table 100. Gene POC Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) by Players (2015-2020)
Table 102. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Players (2015-2020)
Table 103. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) by Regions (2015-2020)
Table 104. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Regions (2015-2020)
Table 105. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
Table 106. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 107. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) by Countries (2015-2020)
Table 108. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) by Countries (2015-2020)
Table 109. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Countries (2015-2020)
Table 110. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 111. Middle East and Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) by Countries (2015-2020)
Table 112. Middle East and Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Table 113. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) by Type (2015-2020)
Table 114. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Type (2015-2020)
Table 115. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Type (2021-2025)
Table 116. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue by Application (2015-2020)
Table 117. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Application (2015-2020)
Table 118. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Forecast by Application (2021-2025)
Table 119. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Point-of-Care Infectious Disease Diagnostics/Testing Picture
Figure 2. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Type in 2019
Figure 3. HIV POC Picture
Figure 4. Clostridium difficile POC Picture
Figure 5. HBV POC Picture
Figure 6. Pneumonia or Streptococcus associated infections Picture
Figure 7. Respiratory syncytial virus (RSV) POC Picture
Figure 8. HPV POC Picture
Figure 9. Influenza/Flu POC Picture
Figure 10. Other Infectious Disease POC Picture
Figure 11. Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Application in 2019
Figure 12. Hospitals Picture
Figure 13. Clinics Picture
Figure 14. Home Picture
Figure 15. Assisted Living Healthcare Facilities Picture
Figure 16. Laboratories Picture
Figure 17. Others Picture
Figure 18. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Middle East and Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Players in 2019
Figure 26. Global Top 5 Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share in 2019
Figure 27. Global Top 10 Players Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share in 2019
Figure 28. Key Players Market Share Trend
Figure 29. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 30. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Regions (2015-2020)
Figure 31. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Regions in 2018
Figure 32. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 33. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 34. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 35. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 36. Middle East and Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 37. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Figure 38. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries in 2019
Figure 39. USA Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 40. Canada Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 41. Mexico Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 42. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Figure 43. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries in 2019
Figure 44. Germany Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 45. UK Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 46. France Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 47. Russia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 48. Italy Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 49. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Figure 50. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries in 2019
Figure 51. China Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 52. Japan Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 53. Korea Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 54. India Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 55. Southeast Asia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 56. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Figure 57. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries in 2019
Figure 58. Brazil Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 59. Argentina Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 60. Middle East and Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries (2015-2020)
Figure 61. Middle East and Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share by Countries in 2019
Figure 62. Saudi Arabia Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 63. UAE Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 64. Egypt Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 65. South Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue and Growth Rate (2015-2020)
Figure 66. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Type (2015-2020)
Figure 67. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Type in 2019
Figure 68. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share Forecast by Type (2021-2025)
Figure 69. Global HIV POC Revenue Growth Rate (2015-2020)
Figure 70. Global Clostridium difficile POC Revenue Growth Rate (2015-2020)
Figure 71. Global HBV POC Revenue Growth Rate (2015-2020)
Figure 72. Global Pneumonia or Streptococcus associated infections Revenue Growth Rate (2015-2020)
Figure 73. Global Respiratory syncytial virus (RSV) POC Revenue Growth Rate (2015-2020)
Figure 74. Global HPV POC Revenue Growth Rate (2015-2020)
Figure 75. Global Influenza/Flu POC Revenue Growth Rate (2015-2020)
Figure 76. Global Other Infectious Disease POC Revenue Growth Rate (2015-2020)
Figure 77. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Application (2015-2020)
Figure 78. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Share by Application in 2019
Figure 79. Global Point-of-Care Infectious Disease Diagnostics/Testing Market Share Forecast by Application (2021-2025)
Figure 80. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 81. Global Clinics Revenue Growth Rate (2015-2020)
Figure 82. Global Home Revenue Growth Rate (2015-2020)
Figure 83. Global Assisted Living Healthcare Facilities Revenue Growth Rate (2015-2020)
Figure 84. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 85. Global Others Revenue Growth Rate (2015-2020)
Figure 86. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 87. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 88. Global Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 89. North America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
Figure 90. Europe Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
Figure 91. Asia-Pacific Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
Figure 92. South America Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
Figure 93. Middle East and Africa Point-of-Care Infectious Disease Diagnostics/Testing Revenue Market Forecast (2021-2025)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
感染症用POC検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point of Care Testing for Infectious Disease market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …- POC検査の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Point of Care Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 23730 million by 2025, from USD 20400 million in 2019. The Point of Care Te…
- 感染症検査における分子診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics in Infectious Disease Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- 臨床現場即時検査（POCT）デバイスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Point-of-Care Testing (POCT) Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Point-of…
- 腸疾患検査＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Enteric Disease Testing and Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3273.4 million by 2025, from USD 3101.6 million in 2019. …